Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
R S Weinstein, … , A M Parfitt, S C Manolagas
R S Weinstein, … , A M Parfitt, S C Manolagas
Published July 15, 1998
Citation Information: J Clin Invest. 1998;102(2):274-282. https://doi.org/10.1172/JCI2799.
View: Text | PDF
Research Article Article has an altmetric score of 17

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

  • Text
  • PDF
Abstract

Glucocorticoid-induced bone disease is characterized by decreased bone formation and in situ death of isolated segments of bone (osteonecrosis) suggesting that glucocorticoid excess, the third most common cause of osteoporosis, may affect the birth or death rate of bone cells, thus reducing their numbers. To test this hypothesis, we administered prednisolone to 7-mo-old mice for 27 d and found decreased bone density, serum osteocalcin, and cancellous bone area along with trabecular narrowing. These changes were accompanied by diminished bone formation and turnover, as determined by histomorphometric analysis of tetracycline-labeled vertebrae, and impaired osteoblastogenesis and osteoclastogenesis, as determined by ex vivo bone marrow cell cultures. In addition, the mice exhibited a threefold increase in osteoblast apoptosis in vertebrae and showed apoptosis in 28% of the osteocytes in metaphyseal cortical bone. As in mice, an increase in osteoblast and osteocyte apoptosis was documented in patients with glucocorticoid-induced osteoporosis. Decreased production of osteoclasts explains the reduction in bone turnover, whereas decreased production and apoptosis of osteoblasts would account for the decline in bone formation and trabecular width. Furthermore, accumulation of apoptotic osteocytes may contribute to osteonecrosis. These findings provide evidence that glucocorticoid-induced bone disease arises from changes in the numbers of bone cells.

Authors

R S Weinstein, R L Jilka, A M Parfitt, S C Manolagas

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 1992 1991 1988 1974 1968 1966 Total
Citations: 11 22 28 34 52 51 45 53 57 62 49 55 53 68 69 56 63 46 55 52 52 33 50 42 40 37 11 1 1 1 1 1 1 1 1 3 1257
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2022 (34)

Title and authors Publication Year
The Role of Alterations in Alpha-Klotho and FGF-23 in Kidney Transplantation and Kidney Donation
M Gupta, G Orozco, M Rao, R Gedaly, H Malluche, J Neyra
Frontiers in Medicine 2022
Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice
B Krüger, L Steppe, S Vettorazzi, M Haffner-Luntzer, S Lee, A Dorn, A Ignatius, J Tuckermann, M Ahmad
Biomedicines 2022
The osteocyte as a signaling cell
J Delgado-Calle, T Bellido
Physiological reviews 2022
Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis
C Chen, S Rao, T Yue, Y Tan, H Yin, L Chen, M Luo, Z Wang, Y Wang, C Hong, Y Qian, Z He, J Liu, F Yang, F Huang, S Tang, H Xie
Science Advances 2022
Skeletal Aging
Sfeir JG, Drake MT, Khosla S, Farr JN
Mayo Clinic Proceedings 2022
The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides.
Box CD, Cronin O, Hauser B
Frontiers in Endocrinology 2022
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.
Gado M, Baschant U, Hofbauer LC, Henneicke H
Frontiers in Endocrinology 2022
Intravenous Transplantation of Human Hair Follicle-Derived Mesenchymal Stem Cells Ameliorates Trabecular Bone Loss in Osteoporotic Mice.
Lin L, He E, Wang H, Guo W, Wu Z, Huang K, Zhao Q
Frontiers in Cell and Developmental Biology 2022
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti S, Villa I, Rubinacci A
Bone Research 2022
Therapeutic perspectives of exosomes in glucocorticoid-induced osteoarthrosis
Lv B, Cheng Z, Yu Y, Chen Y, Gan W, Li S, Zhao K, Yang C, Zhang Y
Frontiers in Surgery 2022
Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy.
Mazur CM, Castro Andrade CD, Tokavanich N, Sato T, Bruce M, Brooks DJ, Bouxsein ML, Wang JS, Wein MN
iScience 2022
Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
Abtahi S, Driessen JHM, Burden AM, Souverein PC, van den Bergh JP, van Staa TP, Boonen A, de Vries F
Rheumatology (Oxford, England) 2022
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment.
Jensen P, Jakobsen LH, Bøgsted M, Baech J, Lykkeboe S, Severinsen MT, Vestergaard P, El-Galaly TC
Blood Advances 2022
Natural History of Bone Disease following Kidney Transplantation.
Jørgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, Cavalier E, D'Haese P, Evenepoel P
Journal of the American Society of Nephrology : JASN 2022
3D Printed Scaffold Based on Type I Collagen/PLGA_TGF-β1 Nanoparticles Mimicking the Growth Factor Footprint of Human Bone Tissue.
Banche-Niclot F, Licini C, Montalbano G, Fiorilli S, Mattioli-Belmonte M, Vitale-Brovarone C
Polymers 2022
Metabolic Profiling Analysis of the Effect and Mechanism of Gushiling Capsule in Rabbits With Glucocorticoid-Induced Osteonecrosis of the Femoral Head.
Mei R, Chen D, Zhong D, Li G, Lin S, Zhang G, Chen K, Yu X
Frontiers in pharmacology 2022
Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis.
Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N
British Medical Bulletin 2022
Neuroendocrine-Immune Regulatory Network of Eucommia ulmoides Oliver.
Zhao Y, Tan DC, Peng B, Yang L, Zhang SY, Shi RP, Chong CM, Zhong ZF, Wang SP, Liang QL, Wang YT
Molecules (Basel, Switzerland) 2022
Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.
Rymuza J, Gutowska K, Kurpios-Piec D, Struga M, Miśkiewicz P
Journal of Clinical Medicine 2022
The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process.
Mannino F, D'Angelo T, Pallio G, Ieni A, Pirrotta I, Giorgi DA, Scarfone A, Mazziotti S, Booz C, Bitto A, Squadrito F, Irrera N
Nutrients 2022
Prevalence of and Associations With Avascular Necrosis After Pediatric Sepsis: A Single-Center Retrospective Study.
Periasamy U, Chilutti M, Kaplan SL, Hickey CP, Hayes K, Pennington JW, Balamuth F, Fitzgerald JC, Weiss SL
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2022
Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis via the Akt/Bad Signal Pathway In Vitro and In Vivo.
Gu G, Hou D, Jiao G, Wu W, Zhou H, Wang H, Chen Y
Biological Trace Element Research 2022
Gli1+ Osteogenic Progenitors Contribute to Condylar Development and Fracture Repair.
Chen S, Lan L, Lei J, He Y, Zhang Y
Frontiers in Cell and Developmental Biology 2022
Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves' Orbitopathy: A Pilot Study.
Rymuza J, Pelewicz K, Przedlacki J, Miśkiewicz P
Frontiers in Endocrinology 2022
Necroptosis: A new target for prevention of osteoporosis.
Hu X, Wang Z, Kong C, Wang Y, Zhu W, Wang W, Li Y, Wang W, Lu S
Frontiers in Endocrinology 2022
The inflammatory response, a mixed blessing for muscle homeostasis and plasticity
Bouredji Z, Argaw A, Frenette J
Frontiers in physiology 2022
PINK1-mediated mitophagy contributes to glucocorticoid-induced cathepsin K production in osteocytes.
Yuan J, Gao YS, Liu DL, Pang Tai AC, Zhou H, Papadimitriou JM, Zhang CQ, Zheng MH, Gao JJ
Journal of Orthopaedic Translation 2022
The long-term (five years) effects of prednisone therapy in children with frequently relapsing nephrotic syndrome: A controlled study of anthropometric parameters and metabolic abnormalities.
Soliman AT, Hamed N, De Sanctis V, Elbaba M, Alyafei F, Alaaraj N, Ahmad S, Itani M, Al-Naimi F, Khater D
Acta bio-medica : Atenei Parmensis 2022
Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways.
Liu Y, Fu B, Li X, Chen C, Li X, Xu L, Wang B
Frontiers in pharmacology 2022
Naphthenic acid fraction components from oil sands process-affected water from the Athabasca Oil Sands Region impair murine osteoblast differentiation and function.
Gutgesell RM, Jamshed L, Frank RA, Hewitt LM, Thomas PJ, Holloway AC
Journal of applied toxicology : JAT 2022
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
Téllez Arévalo AM, Quaye A, Rojas-Rodríguez LC, Poole BD, Baracaldo-Santamaría D, Tellez Freitas CM
Medicina 2022
Update on the role of glucocorticoid signaling in osteoblasts and bone marrow adipocytes during aging
Bensreti H, Alhamad DW, Gonzalez AM, Pizarro-Mondesir M, Bollag WB, Isales CM, McGee-Lawrence ME
Current Osteoporosis Reports 2022
The association of bone mineral density Z-score with the early postoperative remission and characteristics of bone mineral loss in patients with Cushing's disease: a retrospective study.
Gezer E, Cantürk Z, Selek A, Çetinarslan B, Sözen M, Elen Ö, Anık İ, Ceylan S
Croatian medical journal 2022
Atraumatic osteonecrosis of the humeral head: pathophysiology and current concepts of evaluation and treatment.
Castillo Mercado JS, Rojas Lievano J, Zaldivar B, Barajas C, Fierro G, González JC
2022

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 15 patents
Referenced in 2 clinical guideline sources
376 readers on Mendeley
1 readers on CiteULike
See more details